Analysis of autoantibody epitopes on steroid 21-hydroxylase using a panel of monoclonal antibodies

S Chen1, J Sawicka, L Prentice

  • 1FIRS Laboratories, RSR Limited, Cardiff, Wales, United Kingdom.

Insights

This study characterized mouse monoclonal antibodies to steroid 21-hydroxylase (21-OH) and found that autoantibodies in patients with autoimmune adrenal diseases recognize at least three distinct epitopes on 21-OH, with two being human-specific.

Area of Science:

  • Immunology
  • Endocrinology
  • Autoimmunity

Background:

  • Steroid 21-hydroxylase (21-OH) is a key enzyme in cortisol synthesis.
  • Autoantibodies to 21-OH are associated with autoimmune Addison's disease and related conditions.
  • Understanding the epitopes recognized by these autoantibodies is crucial for disease diagnosis and management.

Purpose of the Study:

  • To produce and characterize monoclonal antibodies (MAbs) against human recombinant 21-OH.
  • To investigate the epitopes recognized by autoantibodies (AAbs) in patients with autoimmune adrenal diseases.
  • To determine if these epitopes are specific to human 21-OH.

Main Methods:

  • Production and characterization of five mouse monoclonal antibodies to human 21-OH.
  • Affinity determination and epitope mapping using 21-OH fragments and competition assays.
  • Immunofluorescence studies on human and bovine adrenal tissues, and human ovarian tissue.

Main Results:

  • The five MAbs recognized distinct epitope regions (ER1, ER2, ER3) on 21-OH.
  • Patient AAbs recognized similar epitopes to the MAbs, with ER2 and ER3 representing major epitopes and ER1 a minor one.
  • AAbs from different autoimmune adrenal disease forms showed no major differences in binding characteristics.
  • Two of the identified epitopes were specific to human 21-OH.

Conclusions:

  • Human 21-OH autoantibodies target at least three distinct epitopes in the C-terminal region of the enzyme.
  • Two of these epitopes are specific to human 21-OH, suggesting potential for human-specific diagnostic or therapeutic targets.
  • The findings advance our understanding of the immunopathology of autoimmune adrenal diseases.